HealthEquity (HQY) – Analysts’ Recent Ratings Updates

A number of firms have modified their ratings and price targets on shares of HealthEquity (NASDAQ: HQY) recently:

• 6/1/2026 – HealthEquity was given a new $111.00 price target by Wells Fargo & Company.
• 6/1/2026 – HealthEquity had its “market outperform” rating reaffirmed by Citigroup Inc..
• 6/1/2026 – HealthEquity had its price target raised by Citizens Jmp from $110.00 to $111.00. They now have a “market outperform” rating on the stock.
• 5/29/2026 – HealthEquity had its price target raised by Royal Bank Of Canada from $100.00 to $108.00. They now have an “outperform” rating on the stock.
• 5/26/2026 – HealthEquity had its “overweight” rating reaffirmed by KeyCorp.
• 5/22/2026 – HealthEquity had its “outperform” rating reaffirmed by Barrington Research. They now have a $110.00 price target on the stock.
• 5/9/2026 – HealthEquity was downgraded by Wall Street Zen from “buy” to “hold”.
• 4/11/2026 – HealthEquity was upgraded by Wall Street Zen from “hold” to “buy”.
• 4/9/2026 – HealthEquity was upgraded by BMO Capital Markets from “market perform” to “outperform”. They now have a $105.00 price target on the stock, up from $85.00.

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.